Skip to main content
. 2022 Feb 27;23(5):2618. doi: 10.3390/ijms23052618
amyloid ß
ACh acetylcholine
AChE acetylcholinesterase
AD Alzheimer’s disease
Amg amygdala
AMPARs α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-type glutamate receptors
BDNF brain-derived neurotrophic factor
BRS brain reward system
Cdk5 cyclin-dependent kinase 5
CNS central nervous system
CUMS chronic unpredictable mild stress
DA dopamine
DARPP-32 cAMP-regulated phosphoprotein 32
DBS deep brain stimulation
D1R D1 dopamine receptor
GABA γ-aminobutyric acid
GABAARs γ-aminobutyric acid A receptors
Glu glutamate
GluD1R glutamate delta-1 receptor
HD Huntington’s disease
Hip hippocampus
5-HT serotonin
LTP long-term potentiation
MDD major depressive disorder
MGluRs metabotropic glutamatergic receptors
MSNs medium spiny neurons
mPFC medial prefrontal cortex
NAc nucleus accumbens
NADPH-d dihydronicotinamide adenine dinucleotide phosphate diaphorase
NMDARs N-methyl-D-aspartate receptors
NPY neuropeptide Y
pCREB phosphorylated cAMP (adenosine 3′5′ cyclic monophosphate)-Response Element Binding protein
PD Parkinson’s disease
PFC prefrontal cortex
SOM somatostatin
TPD tangle-predominant dementia
TrkB tropomyosin receptor kinase B
vSub ventral subiculum
VTA ventral tegmental area
Enk enkephalin
SP substance P